Precision medicine models often rely on data from Northern European populations, leading to treatment inequities. Genetic diversity is crucial for understanding disease risk and treatment efficacy, as ...
Johnson and Alistar competed as finalists in CU Boulder’s 2025 Lab Venture Challenge where their technology generated much interest from industry leaders. Access to DNA is crucial in many branches of ...
Existing gene-editing technologies have led to significant advances in both medicine and food production. However, momentum appears to be slowing, particularly in health applications, as early hype is ...
ITHACA, N.Y. – A team of ecologists and engineers from Cornell University have made a breakthrough in understanding environmental DNA (eDNA) movement in water. Researchers developed synthetic DNA that ...
More than 250 million people worldwide live with chronic hepatitis B (HBV), yet there is still no accessible animal model for studying the disease or testing novel therapies. Researchers have now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results